13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001213900-24-097589
Total Value
$1.21B
Positions
43
Other Managers
0
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 6,291,851 | $317.7M | 26.29% |
| 2 | Geron Corp | GERN | 27,225,292 | $123.6M | 10.23% |
| 3 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $104.2M | 8.63% |
| 4 | Verona Pharma PLC | 925050106 | 3,549,758 | $102.1M | 8.45% |
| 5 | Sinovac Biotech Ltd. | SVA | 11,800,000 | $76.3M | 6.32% |
| 6 | Terns Pharmaceuticals Inc | TERN | 6,895,746 | $57.5M | 4.76% |
| 7 | Instil Bio Inc | TIL | 624,339 | $42.0M | 3.48% |
| 8 | Dyne Therapeutics Inc | DYN | 1,114,960 | $40.0M | 3.31% |
| 9 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $38.2M | 3.16% |
| 10 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $35.2M | 2.91% |
| 11 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $20.1M | 1.66% |
| 12 | Zenas Biopharma Inc | ZBIO | 1,183,260 | $20.0M | 1.66% |
| 13 | Erasca Inc | ERAS | 6,756,756 | $18.4M | 1.53% |
| 14 | Olema Pharmaceuticals Inc | OLMA | 1,505,862 | $18.0M | 1.49% |
| 15 | Astria Therapeutics Inc | 04635X102 | 1,552,685 | $17.1M | 1.41% |
| 16 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $15.2M | 1.26% |
| 17 | Rezolute Inc | RZLT | 2,797,704 | $13.6M | 1.12% |
| 18 | Oric Pharmaceuticals Inc | ORIC | 1,277,818 | $13.1M | 1.08% |
| 19 | Sera Prognostics Inc | SERA | 1,650,440 | $12.9M | 1.07% |
| 20 | Cogent Biosciences Inc | COGT | 1,122,471 | $12.1M | 1.00% |
| 21 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $11.6M | 0.96% |
| 22 | Compass Pathway PLC | CMPS | 1,608,000 | $10.1M | 0.84% |
| 23 | Celcuity Inc | CELC | 610,500 | $9.1M | 0.75% |
| 24 | Delcath Systems, Inc. | DCTH | 997,005 | $9.0M | 0.75% |
| 25 | Corvus Pharmaceuticals Holdings | CRVS | 1,497,268 | $7.9M | 0.65% |
| 26 | Regulus Therapeutics Inc | 75915K309 | 5,000,000 | $7.8M | 0.65% |
| 27 | ALX Oncology Holdings Inc | ALXO | 4,034,522 | $7.3M | 0.61% |
| 28 | Compass Therapeutics Inc | CMPX | 3,556,023 | $6.5M | 0.54% |
| 29 | IO Biotech Inc | IOBT | 6,173,439 | $6.5M | 0.54% |
| 30 | Adverum Biotechnologies, Inc. | 00773U207 | 833,333 | $5.8M | 0.48% |
| 31 | Trevi Therapeutics Inc | TRVI | 1,612,903 | $5.4M | 0.45% |
| 32 | Verastem Inc | VSTM | 1,538,461 | $4.6M | 0.38% |
| 33 | Engene Holdings Inc. | ENGNW | 678,705 | $4.5M | 0.37% |
| 34 | Corbus Pharmaceuticals Holdings | CRBP | 166,794 | $3.4M | 0.28% |
| 35 | Bolt Therapeutics Inc | BOLT | 3,521,291 | $2.3M | 0.19% |
| 36 | Allakos Inc | 01671P100 | 2,956,110 | $1.9M | 0.16% |
| 37 | Unicycive Therapeutics | UNCY | 4,470,152 | $1.8M | 0.15% |
| 38 | Aligos Therapeutics Inc | ALGS | 141,879 | $1.2M | 0.10% |
| 39 | Codexis, Inc | CDXS | 388,144 | $1.2M | 0.10% |
| 40 | DBV Technologies SA | DBVTF | 1,354,437 | $948,106 | 0.08% |
| 41 | Q32 Bio Inc. | QTTB | 20,559 | $917,343 | 0.08% |
| 42 | Tenax Therapeutics Inc | TENX | 208,333 | $720,832 | 0.06% |
| 43 | Precision Biosciences Inc | DTIL | 4,675 | $41,888 | 0.00% |